192 related articles for article (PubMed ID: 26374428)
1. Modification of Occupational Exposures on Bladder Cancer Risk by Common Genetic Polymorphisms.
Figueroa JD; Koutros S; Colt JS; Kogevinas M; Garcia-Closas M; Real FX; Friesen MC; Baris D; Stewart P; Schwenn M; Johnson A; Karagas MR; Armenti KR; Moore LE; Schned A; Lenz P; Prokunina-Olsson L; Banday AR; Paquin A; Ylaya K; Chung JY; Hewitt SM; Nickerson ML; Tardón A; Serra C; Carrato A; García-Closas R; Lloreta J; Malats N; Fraumeni JF; Chanock SJ; Chatterjee N; Rothman N; Silverman DT
J Natl Cancer Inst; 2015 Nov; 107(11):. PubMed ID: 26374428
[TBL] [Abstract][Full Text] [Related]
2. RE: Modification of Occupational Exposures on Bladder Cancer Risk by Common Genetic Polymorphisms.
Selinski S; Krech E; Ovsiannikov D; Blaszkewicz M; Hengstler JG; Golka K
J Natl Cancer Inst; 2016 Mar; 108(3):. PubMed ID: 26857137
[No Abstract] [Full Text] [Related]
3. Bladder cancer and occupational exposure to metalworking fluid mist: a counter-matched case-control study in French steel-producing factories.
Colin R; Grzebyk M; Wild P; Hédelin G; Bourgkard È
Occup Environ Med; 2018 May; 75(5):328-336. PubMed ID: 29374095
[TBL] [Abstract][Full Text] [Related]
4. Occupational bladder cancer: Polymorphisms of xenobiotic metabolizing enzymes, exposures, and prognosis.
Lukas C; Selinski S; Prager HM; Blaszkewicz M; Hengstler JG; Golka K
J Toxicol Environ Health A; 2017; 80(7-8):439-452. PubMed ID: 28696839
[TBL] [Abstract][Full Text] [Related]
5. Impact of Occupational Exposures and Genetic Polymorphisms on Recurrence and Progression of Non-Muscle-Invasive Bladder Cancer.
Carta A; Pavanello S; Mastrangelo G; Fedeli U; Arici C; Porru S
Int J Environ Res Public Health; 2018 Jul; 15(8):. PubMed ID: 30042310
[No Abstract] [Full Text] [Related]
6. GSTA1, GSTM1, GSTP1, and GSTT1 polymorphisms and susceptibility to smoking-related bladder cancer: a case-control study.
Matic M; Pekmezovic T; Djukic T; Mimic-Oka J; Dragicevic D; Krivic B; Suvakov S; Savic-Radojevic A; Pljesa-Ercegovac M; Tulic C; Coric V; Simic T
Urol Oncol; 2013 Oct; 31(7):1184-92. PubMed ID: 24075358
[TBL] [Abstract][Full Text] [Related]
7. Response.
Figueroa JD; Prokunina-Olsson L; Koutros S; Garcia-Closas M; Chanock S; Silverman DT; Rothman N
J Natl Cancer Inst; 2016 Mar; 108(3):. PubMed ID: 26857138
[No Abstract] [Full Text] [Related]
8. GST, NAT, SULT1A1, CYP1B1 genetic polymorphisms, interactions with environmental exposures and bladder cancer risk in a high-risk population.
Hung RJ; Boffetta P; Brennan P; Malaveille C; Hautefeuille A; Donato F; Gelatti U; Spaliviero M; Placidi D; Carta A; Scotto di Carlo A; Porru S
Int J Cancer; 2004 Jul; 110(4):598-604. PubMed ID: 15122594
[TBL] [Abstract][Full Text] [Related]
9. Association of genetic polymorphism of glutathione S-transferase (GSTM1, GSTT1, GSTP1) with bladder cancer susceptibility.
Safarinejad MR; Safarinejad S; Shafiei N; Safarinejad S
Urol Oncol; 2013 Oct; 31(7):1193-203. PubMed ID: 22154357
[TBL] [Abstract][Full Text] [Related]
10. Does occupational exposure to PAHs, diesel and aromatic amines interact with smoking and metabolic genetic polymorphisms to increase the risk on bladder cancer?; The Belgian case control study on bladder cancer risk.
Kellen E; Zeegers M; Paulussen A; Vlietinck R; Vlem EV; Veulemans H; Buntinx F
Cancer Lett; 2007 Jan; 245(1-2):51-60. PubMed ID: 16504378
[TBL] [Abstract][Full Text] [Related]
11. Occupation and bladder cancer in a population-based case-control study in Northern New England.
Colt JS; Karagas MR; Schwenn M; Baris D; Johnson A; Stewart P; Verrill C; Moore LE; Lubin J; Ward MH; Samanic C; Rothman N; Cantor KP; Beane Freeman LE; Schned A; Cherala S; Silverman DT
Occup Environ Med; 2011 Apr; 68(4):239-49. PubMed ID: 20864470
[TBL] [Abstract][Full Text] [Related]
12. Effect of occupational exposures on lung cancer susceptibility: a study of gene-environment interaction analysis.
Malhotra J; Sartori S; Brennan P; Zaridze D; Szeszenia-Dabrowska N; Świątkowska B; Rudnai P; Lissowska J; Fabianova E; Mates D; Bencko V; Gaborieau V; Stücker I; Foretova L; Janout V; Boffetta P
Cancer Epidemiol Biomarkers Prev; 2015 Mar; 24(3):570-9. PubMed ID: 25583949
[TBL] [Abstract][Full Text] [Related]
13. Organochlorine Pesticides Exposure and Bladder Cancer: Evaluation from a Gene-Environment Perspective in a Hospital-Based Case-Control Study in the Canary Islands (Spain).
Boada LD; Henríquez-Hernández LA; Zumbado M; Almeida-González M; Álvarez-León EE; Navarro P; Luzardo OP
J Agromedicine; 2016; 21(1):34-42. PubMed ID: 26479327
[TBL] [Abstract][Full Text] [Related]
14. Constitutional and occupational risk factors associated with bladder cancer.
Ferrís J; Garcia J; Berbel O; Ortega JA
Actas Urol Esp; 2013 Sep; 37(8):513-22. PubMed ID: 23664103
[TBL] [Abstract][Full Text] [Related]
15. Rs11892031[A] on chromosome 2q37 in an intronic region of the UGT1A locus is associated with urinary bladder cancer risk.
Selinski S; Lehmann ML; Blaszkewicz M; Ovsiannikov D; Moormann O; Guballa C; Kress A; Truss MC; Gerullis H; Otto T; Barski D; Niegisch G; Albers P; Frees S; Brenner W; Thüroff JW; Angeli-Greaves M; Seidel T; Roth G; Volkert F; Ebbinghaus R; Prager HM; Bolt HM; Falkenstein M; Zimmermann A; Klein T; Reckwitz T; Roemer HC; Hartel M; Weistenhöfer W; Schöps W; Rizvi SA; Aslam M; Bánfi G; Romics I; Ickstadt K; Hengstler JG; Golka K
Arch Toxicol; 2012 Sep; 86(9):1369-78. PubMed ID: 22532026
[TBL] [Abstract][Full Text] [Related]
16. A sequence variant at 4p16.3 confers susceptibility to urinary bladder cancer.
Kiemeney LA; Sulem P; Besenbacher S; Vermeulen SH; Sigurdsson A; Thorleifsson G; Gudbjartsson DF; Stacey SN; Gudmundsson J; Zanon C; Kostic J; Masson G; Bjarnason H; Palsson ST; Skarphedinsson OB; Gudjonsson SA; Witjes JA; Grotenhuis AJ; Verhaegh GW; Bishop DT; Sak SC; Choudhury A; Elliott F; Barrett JH; Hurst CD; de Verdier PJ; Ryk C; Rudnai P; Gurzau E; Koppova K; Vineis P; Polidoro S; Guarrera S; Sacerdote C; Campagna M; Placidi D; Arici C; Zeegers MP; Kellen E; Gutierrez BS; Sanz-Velez JI; Sanchez-Zalabardo M; Valdivia G; Garcia-Prats MD; Hengstler JG; Blaszkewicz M; Dietrich H; Ophoff RA; van den Berg LH; Alexiusdottir K; Kristjansson K; Geirsson G; Nikulasson S; Petursdottir V; Kong A; Thorgeirsson T; Mungan NA; Lindblom A; van Es MA; Porru S; Buntinx F; Golka K; Mayordomo JI; Kumar R; Matullo G; Steineck G; Kiltie AE; Aben KK; Jonsson E; Thorsteinsdottir U; Knowles MA; Rafnar T; Stefansson K
Nat Genet; 2010 May; 42(5):415-9. PubMed ID: 20348956
[TBL] [Abstract][Full Text] [Related]
17. Chromosome 4p16.3 variant modify bladder cancer risk in a Chinese population.
Wang M; Chu H; Yan F; Qin C; Li P; Yuan L; Yin C; Xu J; Zhang Z
Carcinogenesis; 2011 Jun; 32(6):872-5. PubMed ID: 21459758
[TBL] [Abstract][Full Text] [Related]
18. p53 mutations in bladder cancer: evidence for exogenous versus endogenous risk factors.
Schroeder JC; Conway K; Li Y; Mistry K; Bell DA; Taylor JA
Cancer Res; 2003 Nov; 63(21):7530-8. PubMed ID: 14612556
[TBL] [Abstract][Full Text] [Related]
19. Polymorphism of glutathione S-transferase T1, M1 and P1 genes in a Shanghai population: patients with occupational or non-occupational bladder cancer.
Ma QW; Lin GF; Chen JG; Shen JH
Biomed Environ Sci; 2002 Sep; 15(3):253-60. PubMed ID: 12500666
[TBL] [Abstract][Full Text] [Related]
20. Susceptibility to urinary bladder cancer: relevance of rs9642880[T], GSTM1 0/0 and occupational exposure.
Golka K; Hermes M; Selinski S; Blaszkewicz M; Bolt HM; Roth G; Dietrich H; Prager HM; Ickstadt K; Hengstler JG
Pharmacogenet Genomics; 2009 Nov; 19(11):903-6. PubMed ID: 19801959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
